BRD2 and cancer: This TME provides oxygen and nutrients to meet the heightened metabolic demands of the tumor cells.[68] NAT can be considered precancerous, and investigating its metabolic alteration during the CAC stage offers valuable insights into the inflammation‐to‐cancer transition.